The deal will also help Amylin develop a sales force ahead of the launch of Symlin.
FORBES: Magazine Article
2.
Two weeks ago, for instance, Bristol Myers Squibb acquired Amylin Pharmaceuticals (NASDAQ:AMLN), which has won approval for two diabetes drugs, BYETTA and SYMLIN.
FORBES: Pharmaceuticals Trading Near 52-Week Highs